Zheng, T., Kim, N., & Yim, M. (2017). Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways. J Bone Metab.
Citação norma ChicagoZheng, Ting, Na-Young Kim, and Mijung Yim. "Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation Via Nuclear Factor of Activated T Cells Signaling Pathways." J Bone Metab 2017.
Citação norma MLAZheng, Ting, Na-Young Kim, and Mijung Yim. "Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation Via Nuclear Factor of Activated T Cells Signaling Pathways." J Bone Metab 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.